Vasant Narasimhan appointed CEO of Novartis; Joseph Jimenez to retire

Vasant Narasimhan, global head of drug development and chief medical officer of Novartis, is to become the company’s chief executive on 1 February 2018, succeeding Joseph Jimenez who has held the job since 2010.

Full text available to subscribers only. Click here for information on subscribing to MedNous.